Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid Prescribing Guidelines Put US FDA In Unfamiliar Territory

Oct 04 2018

• By Michael McCaughan

People running from dangerous pills

Related Content

Opioid REMS Increases Nearly Six-Fold As US FDA Adds Immediate-Release Products

Sep 19 2018

Opioid Approvals: Congress Wants US FDA Guidance On Abuse Potential

Oct 01 2018

Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling

Dec 12 2017

Opioid Policy At US FDA To Become 'More Forceful,' Gottlieb Says

May 24 2017

Additional Topics

United States Legislation Regulation FDA Neurology BioPharmaceutical

More from Legislation

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window